With an expiration date still more than a year away, here's what the latest details reveal.

It has long been assumed that psychostimulants help those with ADHD by acting on the brain’s attention circuitry. However, new research finds that this is not the case.

FDA fast tracks ADHD drug centanafadine, targeting approval by July 24 for treatment across all age groups, based on phase 3 trial results.

Women are driving soaring use of ADHD medication, experts say. Researchers from the University of Oxford highlighted a 20-fold rise in use of drugs to manage the condition among w ...

The Prescription Drug User Fee Act target action date for the NDA is scheduled for 24 July 2026.

Finding the right ADHD prescription can feel overwhelming at first. With dozens of stimulant and nonstimulant ADHD medications available, many people search for clarity on how these medications work, ...

From 2022 to 2024, stimulant prescriptions issued in Connecticut increased by 13.2 percent, according to data from the state.

Changes proposed by the Allan government will seek to cut down a process that can take up to a year and costs at least $2000.

The Royal Australian College of GPs (RACGP) and Royal Australian and New Zealand College of Psychiatrists (RANZCP) have called on the Victorian ...

ADHD New Zealand spokesperson Darrin Bull joins Mike Hosking to discuss the significant prescription law change that will make ADHD treatment easier to acc ...